| Agonist-mediated activation of STING induces apoptosis in malignant B cells CHA Tang, JA Zundell, S Ranatunga, C Lin, Y Nefedova, JR Del Valle, ... Cancer research 76 (8), 2137-2152, 2016 | 274 | 2016 |
| NAD+ metabolism governs the proinflammatory senescence-associated secretome T Nacarelli, L Lau, T Fukumoto, J Zundell, N Fatkhutdinov, S Wu, KM Aird, ... Nature cell biology 21 (3), 397-407, 2019 | 272 | 2019 |
| NAMPT inhibition suppresses cancer stem-like cells associated with therapy-induced senescence in ovarian cancer T Nacarelli, T Fukumoto, JA Zundell, N Fatkhutdinov, S Jean, ... Cancer research 80 (4), 890-900, 2020 | 98 | 2020 |
| HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer T Fukumoto, N Fatkhutdinov, JA Zundell, EN Tcyganov, T Nacarelli, ... Cancer research 79 (21), 5482-5489, 2019 | 81 | 2019 |
| ARID1A promotes genomic stability through protecting telomere cohesion B Zhao, J Lin, L Rong, S Wu, Z Deng, N Fatkhutdinov, J Zundell, ... Nature communications 10 (1), 4067, 2019 | 48 | 2019 |
| Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma S Wu, T Fukumoto, J Lin, T Nacarelli, Y Wang, D Ong, H Liu, ... Nature cancer 2 (2), 189-200, 2021 | 47 | 2021 |
| Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer J Lin, H Liu, T Fukumoto, J Zundell, Q Yan, CHA Tang, S Wu, W Zhou, ... Nature communications 12 (1), 5321, 2021 | 25 | 2021 |
| Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers JA Zundell, T Fukumoto, J Lin, N Fatkhudinov, T Nacarelli, AV Kossenkov, ... Cancer research 81 (20), 5325-5335, 2021 | 18 | 2021 |
| Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis W Zhou, H Liu, Z Yuan, J Zundell, M Towers, J Lin, S Lombardi, H Nie, ... Cancer cell 41 (4), 740-756. e10, 2023 | 15 | 2023 |
| CA (2016) CHA Tang, JA Zundell, S Ranatunga, C Lin, Y Nefedova, JR Del Valle, ... Agonist-mediated activation of STING induces apoptosis in malignant B cells …, 0 | 13 | |
| Treatment of carm1-overexpressing and/or arid1a mutant cancers with ire-1/xbp-1 inhibitors R Zhang, J Zundell, J Lin US Patent App. 17/905,143, 2023 | | 2023 |
| Targeting the IRE1⍺/XBP1 Endoplasmic Reticulum Stress Response in ARID1A Mutant Ovarian Clear Cell Carcinoma J Zundell University of the Sciences in Philadelphia, 2022 | | 2022 |
